RobalzotanRobalzotan (INN, BAN; developmental code names NAD-299 and AZD-7371) is a selective serotonin 5-HT1A receptor antagonist which was under development for the treatment of major depressive disorder, anxiety disorders, gastrointestinal disorders, irritable bowel syndrome (IBS), and overactive bladder but was never… Read from the Drugbox of the Wikipedia article Robalzotan, revision 1367004395.

Property

Value

Formula

C18H23FN2O2, 318.39 g/mol

Bioavailability

14.5 %

Protein binding

2 %

Elimination half-life

1.5 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.